loader image
Thursday, November 7, 2024
90.4 F
McAllen
We Welcome your Press Release
- Advertisement -

 Survey: Many Doctors Concerned About Physician Involvement in Concealed-Weapon Permit Process

Translate to Spanish or other 102 languages!

This is Dr. Adam Goldstein, corresponding author of the study and a professor in the Department of Family Medicine at the University of North Carolina School of Medicine.
This is Dr. Adam Goldstein, corresponding author of the study and a professor in the Department of Family Medicine at the University of North Carolina School of Medicine.

A majority said they were worried about potential ethical consequences in the doctor-patient relationship 

- Advertisement -

Mega Doctor News-Newswise — A new survey of North Carolina doctors finds that many are concerned about the increasing number of requests they are receiving to assess their patients’ competency to carry concealed weapons.

In particular, a majority of physicians who responded to the survey said they were worried about the potential ethical consequences in the doctor-patient relationship if they participated in the concealed-weapon permit process.

“This is not a small problem,” said Dr. Adam Goldstein, corresponding author of the study and a professor in the Department of Family Medicine at the University of North Carolina School of Medicine. “More than 20 percent of the physicians we surveyed have been asked to sign competency permits for concealed weapons, and a majority of them do not feel they can adequately assess the physical or mental competence of their patients to safely have a concealed weapons permit.”

- Advertisement -

The study, published as a research letter in the June 29, 2014 issue of the New England Journal of Medicine, is believed to be the first that examines physicians’ attitudes, beliefs and behaviors regarding their emerging role in the assessment of physical and mental competency and the licensing of concealed weapons.

First author of the study is John Pierson, a second-year medical student at UNC. Co-authors are Adam Goldstein, MD, MPH; Anthony Viera, MD, MPH; and Kathy Barnhouse, MD from the UNC School of Medicine; James Tulsky MD from the Duke University School of Medicine; and Barak Richman, JD, PhD from the Duke University School of Law.

The survey was sent to 600 physicians registered with the North Carolina Medical Board and in active practice in October 2013. Of the 600 surveys sent, 225 completed surveys were returned.

The survey found that physicians involved in concealed-weapon permitting sign off on permits almost 80 percent of the time, despite their uncertainty. “If physicians do not feel that they can adequately assess their patients’ competence yet are still giving approval for concealed-weapon permits, then there is something wrong with the system,” Pierson said.

- Advertisement -

“There are things we can do now to change this,” said Barnhouse, a professor of Family Medicine at UNC. “We discovered that the great majority of physicians feel that assessments for concealed weapons permits should best be done by providers specifically trained in making such assessments, presumably with standards to make assessments about mental and physical competence.”

The study concludes that more research in this area is needed.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Second Chance at a Dream Career

Second chance at a dream career, STC honors 92 Vocational Nursing graduates

RGV College Celebrates Launch of Groundbreaking Nurse Apprenticeship Program with White Coat Ceremony

Traditionally, nursing students have to balance their studies with employment obligations.

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.
- Advertisement -
×